Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral ...
Fintel reports that on December 13, 2024, Morgan Stanley initiated coverage of Sonida Senior Living (NYSE:SNDA) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 78.68% Downside ...
(RTTNews) - Johnson & Johnson (JNJ), Tuesday announced that the U.S. Food and Drug Administration has approved supplemental New Drug Application or sNDA for Spravato, a monotherapy for adults with ...